000 01500cam a2200337 a 4500
001 159324
005 20160428135749.0
008 980225s1998 enka 101 0 eng d
010 _a 98139493
020 _a0792387295 :
_c£50.00
035 _a(OCoLC)38550070
040 _aUk
_cUk
_dMoU
_dDLC
042 _alccopycat
050 0 0 _aRM405.5
_b.S45 1998
082 0 0 _a615.7
_221
245 0 0 _aSelective COX-2 inhibitors :
_bpharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France /
_cedited by Sir John Vane and Jack Botting.
260 _aDordrecht ;
_aLondon :
_bKluwer Academic,
_cc1998.
300 _aix, 150 p. :
_bill. ;
_c24 cm.
500 _aThe conference was supported by an educational grant from Boehringer Ingelheim.
500 _aIncludes index.
650 0 _aCyclooxygenases
_xInhibitors
_vCongresses.
_954311
650 0 _aNonsteroidal anti-inflammatory agents
_xCongresses.
_954312
650 1 2 _aCyclooxygenase Inhibitors
_vcongresses.
_954313
650 2 2 _aAnti-Inflammatory Agents, Non-Steroidal
_vcongresses.
_954314
700 1 _aVane, John R.
_954315
700 1 _aBotting, Jack H.
_954316
711 2 _aWilliam Harvey Research Conference
_d(1997 :
_cCannes, France)
_954317
906 _a7
_bcbc
_ccopycat
_d2
_encip
_f19
_gy-gencatlg
942 _2lcc
_cBK
999 _c24343
_d24343